When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LXRP - Lexaria finalizes Phase 1 program on DehydraTECH oral nicotine formulation
Lexaria Bioscience Corp.
Lexaria Bioscience (OTCQX:LXRP+11.5%) concludes Phase 1 study of oral forms of nicotine delivery, utilizing its DehydraTECH technology. The study evaluated reduced health risks relative to combusted tobacco of a preliminary DehydraTECH oral nicotine formulation.
More news on: Lexaria Bioscience Corp., Healthcare stocks news, Stocks on the move,